vitiligo. Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals over 12 years of age with stable non-segmental vitiligo Individuals with less than 20% body surface area involvement Involvement of areas other than the face and neck Presence of at least one vitiligo lesion on each side of the body, with approximately symmetrical location and appearance
Exclusion criteria
Exclusion criteria: Use of conventional vitiligo treatments, such as topical or systemic medications and phototherapy, within the past 3 months. Presence of other Koebner-positive skin diseases. Active disease within the past 6 months, defined as the development of new lesions or progression of existing ones. Pregnancy or breastfeeding. Hypersensitivity to the drug components. Presence of wounds or infections at the procedure site. History of keloid or hypertrophic scar.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extent of the vitiligo lesion. Timepoint: 0,1,2,3,5 month. Method of measurement: Vitiligo Area Scoring Index score.;Percentage of skin repigmentation. Timepoint: At 90 days after study initiation. Method of measurement: Quartile grading scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction score. Timepoint: 0,1,2,3,5 month. Method of measurement: Patient satisfaction score based on treatment response (ranging from 1 to 4): 1 = Not satisfied, 2 = Moderately satisfied, 3 = Satisfied, 4 = Highly satisfied.;Side effects. Timepoint: 1,2,3,5 month. Method of measurement: Investigator’s observations and patient-reported outcomes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences